脑部放疗,上午比下午敏感许多!
& G! i9 l8 q6 f0 K% e. | u/ m% p. V6 l( K( i5 i
3 f6 B/ r+ ~% x& t( v# @Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
5 Y3 ?$ U1 M# Q+ S! V5 `2 n7 ?Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?! Q& `/ g9 Q4 L% d! C7 w* v
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T., r$ N3 X9 l0 ?" J6 v/ U9 Z: j1 j
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
`& r5 G$ o& O% u0 v/ r/ P9 O0 o4 ]$ Q# E- y
Abstract" c3 H) N5 \; a) U" ~/ W
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
% z w0 W' f2 m7 I
9 y, n0 g5 T2 {1 cMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
' U* X2 r6 f$ |. r0 K0 B
# d" e# G4 V5 h/ V3 K) ]% |; ERESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).& U7 w/ i0 y( @6 l9 [
2 T8 m* ]- f% B+ K, Z
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
! [0 s+ \. m- i# P% y( ] I# r
7 T) p! S/ l$ u |